Global Cranial implants market

Global Cranial Implants Market Size, Share, Growth Analysis, By Product(Customized, Non-customized), By Material(Polymer, Ceramic) - Industry Forecast 2024-2031


Report ID: SQMIG35A2430 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 65

Global Cranial Implants Market News

  • In May of 2022, Medartis Holding AG made public its intention to purchase Nextremity Solutions, Inc. for a sum of $100 million. This strategic move by Medartis Holding is expected to expedite the growth of its US extremities division by granting access to an extensive product pipeline, fostering strong connections with American design surgeons, and tapping into the expertise of a seasoned research and development team.
  • In the later part of December 2021, Kelyniam Global, Inc. disclosed its licensing arrangement with Fin-Ceramica Faenza spa, aimed at promoting its patient-specific cranial implant made of hydroxyapatite. Kelyniam Global is confident that this collaboration will empower the company to further enhance its CustomizedBone Cranial Implant within the United States of America.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cranial Implants Market size was valued at USD 1.08 Billion in 2021 and is poised to grow from USD 1.15 Billion in 2022 to USD 1.92 Billion by 2030, at a CAGR of 6.63% during the forecast period (2023-2030).

The competitive landscape of the cranial implants market is characterised by a mix of established medical device companies and innovative startups, each striving to capture a significant share in this rapidly evolving sector. Key players in the market include major medical technology firms with a strong global presence and specialised manufacturers focusing on cranial implants. Prominent players often engage in mergers, acquisitions, partnerships, and collaborations to enhance their product portfolios, expand their geographical reach, and leverage advanced technologies. Research and development initiatives remain crucial to maintain a competitive edge, with a focus on designing customised and patient-specific cranial implant solutions that offer improved biocompatibility, durability, and ease of surgical implantation. Market leaders emphasise regulatory compliance, ensuring that their products meet the highest quality standards and gain the necessary approvals from regulatory authorities. Customer relationships, especially with neurosurgeons, hospitals, and healthcare institutions, play a vital role in driving sales and market penetration. 'B. Braun Melsungen AG', 'DePuy Synthes (Johnson and Johnson)', 'Stryker Corporation', 'Zimmer Biomet', 'Osteomed', 'Synimed', 'Evonos', 'Medartis AG', 'Renishaw Plc', 'Kelyniam Global Inc.'

The increasing incidence of traumatic injuries and neurological disorders, such as brain tumours and other conditions, drives the demand for cranial implants. As the population grows and ages, the occurrence of these disorders is expected to rise, leading to greater demand for cranial implants.

Personalised and Customised Implants: The trend towards personalised medicine has extended to cranial implants. Surgeons increasingly opt for patient-specific cranial implants that are tailored to fit the unique contours of an individual's skull. This customization not only enhances the aesthetic outcome but also improves the overall effectiveness of the implant, leading to better patient outcomes and reducing the risk of complications.

North America has maintained the largest market share and is projected to sustain substantial growth at a rate of approximately 5.5% throughout the forecasted period. This expansion can be attributed to factors such as the prevalence of trauma, brain cancer cases, the adoption of advanced technological solutions, and increased healthcare expenditures by regional governments. For instance, the Canadian Cancer Society estimates that around 3,200 Canadians will be diagnosed with brain and spinal cord cancer in 2022, with gender-specific distributions.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cranial implants market

Product ID: SQMIG35A2430

$5,300
BUY NOW GET FREE SAMPLE